---------------------------- 2025 Platform Presentation Winner --------------------------

 

DNA Methylation Profiling of Uterine Mesenchymal Tumors Suggests Adenosarcomas Are a Heterogeneous Group of Neoplasms

Minami A. Tokuyama, Erna Forgo, Emanuela D'Angelo, Reem Al-Humadi, Leandra G. Kingsley, Arslan Kasimov, Sabrina Zdravkovic, Sarah Lawson, Tamra-Lee McCleary, Jennifer A. Bennett, Carlos Parra-Herran, David L. Kolin, Marisa Rose Nucci, Charles Matthew Quick, Glenn McCluggage, Brooke E. Howitt

Background: Uterine mesenchymal tumors (UMT) are rare neoplasms with overlapping morphologic features and immunophenotypes. In some cases, molecular features are entity-defining (such as YWHAE or ALK fusion), and testing may be necessary for accurate diagnosis. Uterine tumors resembling ovarian sex cord tumors (UTROSCT) display varying degrees of sex cord differentiation (SCD) and harbor frequent NCOA-fusions, differentiating them from most other tumors with SCD. Mullerian adenosarcomas (AS) are malignant UMTs with associated non-neoplastic epithelial components and can also have extensive SCD. No unifying molecular features have been identified in AS, but a subset of these tumors (11%) also harbor NCOA-fusions.

Design: We collected a multicenter cohort of 169 UMTs other than benign leiomyomas, including 34 AS (Fig 1A). DNA was extracted from formalin-fixed paraffin embedded tissue. Methylation data was generated using the Infinium MethylationEPIC v2.0 or v1.0 BeadChip arrays. Unsupervised hierarchical clustering was performed using the top 10,000 probes with the highest median absolute deviation across beta values using Euclidean distance squared and Ward's linkage method. Morphologic features and any known molecular alterations were recorded when available.

Results: Samples run on both the v1.0 and v2.0 arrays (n=6) as well as tumor samples with different locations/timepoints from the same patient (n = 13) showed high concordance (Fig 1B). LGESS and HGESS clustered separately (Fig 1C). Other tumors in diagnostic categories with known recurrent molecular alterations such as UTROSCT and IMT tended to cluster by diagnosis. In contrast, tumors from diagnostic categories without unifying molecular alterations such as AS were not cluster-exclusive. Most AS clustered into 1 of 3 groups: 1) 5 AS clustered with UTROSCT; 2 exhibited SCD, none had sarcomatous overgrowth (SO), and all were low-grade, 2) 7 AS with SO clustered with UUS and 3) 12 AS formed a group with JAZF1-rearranged LGESS and UMTs with ambiguous morphologic features that lacked sequencing data (Fig 2).



Conclusions: Our results suggest some UMT groups, especially AS, have heterogenous underlying biology. Specifically, we confirm the reported molecular similarities between UTROSCT and a subset of AS. Though our study is limited, the data warrant further investigation of molecular-based classification schemes and demonstrate added benefit of methylation profiling in UMTs.

 


Chat With ISGYP

close
First Name *
Last Name *
Email *
Customer ID